Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Atazanavir/r + Lamivudine Dual Therapy (ATLAS)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Simona Di Giambenedetto, Catholic University of the Sacred Heart
ClinicalTrials.gov Identifier:
NCT01599364
First received: May 14, 2012
Last updated: August 14, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: November 2016
  Primary Completion Date: April 2016 (Final data collection date for primary outcome measure)